Correlation between B-cell lymphoma 6 with the balance of T helper-1/2 and severity of allergic rhinitis

Main Article Content

Jiali Wu
Shumei Chen
Xiaoyan Li


Allergic rhinitis, B-cell lymphoma 6, minirhinoconjunctivitis quality-of-life questionnaire, Pearson analysis, quality-of-life, receiver operating characteristics, T helper-1/2


Objective: Allergic rhinitis (AR) is a prevailing immune disorder affecting the nasal mucosa. B-cell lymphoma 6 (BCL6) imposes essential roles in immunity. This study probed into the serum expression of BCL6 and its effect on AR diagnosis and patients’ quality of life (QOL).

Methods: A total of 113 patients with AR including 38 cases with mild AR (MAR) and 75 cases with moderate-severe AR (MSAR) were enrolled, with 101 healthy people enrolled as control. Serum expression of BCL6 was detected by RT-qPCR and the diagnostic efficacy of BCL6 for AR was analyzed using the receiver operating characteristic curve. The proportion of T helper-1/2 (Th1/Th2) cells in CD4+ T cells in peripheral blood mononuclear cells was detected using flow cytometry. The correlation between BCL6 and Th1/Th2 cells and the effects of BCL6 expression on patients’ QOL were assessed by Pearson analysis and Mini-RQLQ questionnaire.

Results: BCL6 was downregulated in patients with AR, serum BCL6 level < 0.8450 had certain auxiliary diagnostic values for AR, and serum BCL6 level < 0.5400 could assist the diagnosis of AR severity. Th1 cell proportion in CD4+ T cells was decreased, whereas Th2 cell proportion was increased with AR severity. BCL6 was positively-linked with Th1 cells but inversely-correlated with Th2 cells in patients with AR. Patients with AR with low BCL6 expression had a poorer QOL compared with high BCL6 expression. The domains most affected by BCL6 expression were practical problems, nasal symptoms, and lacrimation.

Conclusion: Serum BCL6 is downregulated and low BCL6 expression greatly deteriorates QOL in patients with AR.

Abstract 96 | PDF Downloads 68 HTML Downloads 58 XML Downloads 13


1. Rahim NA, Jantan I, Said MM, Jalil J, Abd Razak AF, Husain K. Anti-allergic rhinitis effects of medicinal plants and their bioactive metabolites via suppression of the immune system: a mechanistic review. Front Pharmacol. 2021;12:660083. 10.3389/fphar.2021.660083

2. Vardouniotis A, Doulaptsi M, Aoi N, Karatzanis A, Kawauchi H, Prokopakis E. Local allergic rhinitis revisited. Curr Allergy Asthma Rep. 2020;20(7):22. 10.1007/s11882-020-00925-5

3. Waserman S, Shah A, Avilla E. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis. Ann Allergy Asthma Immunol. 2021; 127(2):165-75. 10.1016/j.anai.2021.05.020

4. Nur Husna SM, Tan HT, Md Shukri N, Mohd Ashari NS, Wong KK. Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: overview and pathogenic insights. Front Immunol. 2021;12:663626. 10.3389/fimmu.2021.663626

5. Zeng Y, Song B, Gao Y, Cao W, Li J, Liu Q, et al. Cumulative evidence for association of acetaminophen exposure and allergic rhinitis. Int Arch Allergy Immunol. 2020;181(6):422-33. 10.1159/000506807

6. Choi BY, Han M, Kwak JW, Kim TH. Genetics and epigenetics in allergic rhinitis. Genes. 2021;12(12):2014. 10.3390/genes12122004

7. Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol Allergy Clin North Am. 2016;36(2):261-78. 10.1016/j.iac.2015.12.004

8. Teo CWL, Png SJY, Ung YW, Yap WN. Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis. Allergy Asthma Clin Immunol. 2022;18(1):52. 10.1186/s13223-022-00695-x

9. Bousquet J, van Cauwenberge P. Allergic rhinitis and its impact on asthma (ARIA) in collaboration with the World Health Organisation. Prim Care Respir J. 2002; 11(1):18-9. 10.1038/pcrj.2002.7

10. Li L, Liu Y, Wang Q, Wang Z, Cui L, Xu Y, et al. Levels of nasal exhaled hydrogen sulfide in the general population and allergic rhinitis patients. J Clin Lab Anal. 2021;35(3):e23678. 10.1002/jcla.23678

11. Li P, Tsang MS, Kan LL, Hou T, Hon SS, Chan BC, et al. The immuno-modulatory activities of pentaherbs formula on ovalbumin-induced allergic rhinitis mice via the activation of Th1 and treg cells and inhibition of Th2 and Th17 cells. Molecules. 2021;27(1):239. 10.3390/molecules27010239

12. Kirtland ME, Tsitoura DC, Durham SR, Shamji MH. Toll-like receptor agonists as adjuvants for allergen immunotherapy. Front Immunol. 2020;11:599083. 10.3389/fimmu.2020.599083

13. Link CWM, Rau CN, Udoye CC, Ragab M, Korkmaz RU, Comduhr S,et al. IL-2-agonist-induced ifn-gamma exacerbates systemic anaphylaxis in food allergen-sensitized mice. Front Immunol. 2020;11:596772. 10.3389/fimmu.2020.596772

14. Dong F, Tan J, Zheng Y. Chlorogenic acid alleviates allergic inflammatory responses through regulating Th1/Th2 balance in ovalbumin-induced allergic rhinitis mice. Med Sci Monit. 2020;26:e923358. 10.12659/MSM.923358

15. Beguelin W, Teater M, Gearhart MD, Calvo Fernandez MT, Goldstein RL, Cardenas MG, et al. EZH2 and BCL6 cooperate to assemble CBX8-BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis. Cancer Cell. 2016; 30(2):197-213. 10.1016/j.ccell.2016.07.006

16. Li Q, Zhou L, Wang L, Li S, Xu G, Gu H, et al. Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis. Eur J Immunol. 2020;50(4):525-36. 10.1002/eji.201948299

17. Basso K, Dalla-Favera R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev. 2012;247(1):172-83. 10.1111/j.1600-065X.2012.01112.x

18. Koh B, Ulrich BJ, Nelson AS, Panangipalli G, Kharwadkar R, Wu W,et al. Bcl6 and Blimp1 reciprocally regulate ST2(+) Treg-cell development in the context of allergic airway inflammation. J Allergy Clin Immunol. 2020;146(5):1121-36. 10.1016/j.jaci.2020.03.002

19. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, et al. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325(5943):1001-5. 10.1126/science.1176676

20. Sawant DV, Wu H, Kaplan MH, Dent AL. The Bcl6 target gene microRNA-21 promotes Th2 differentiation by a T cell intrinsic pathway. Mol Immunol. 2013;54(3-4):435-42. 10.1016/j.molimm.2013.01.006

21. Lemonnier N, Melen E, Jiang Y, Joly S, Menard C, Aguilar D, et al. A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents. Allergy. 2020;75(12):3248-60. 10.1111/all.14314

22. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950-8. 10.1016/j.jaci.2017.03.050

23. Del Cuvillo A, Santos V, Montoro J, Bartra J, Davila I, Ferrer M, et al. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe. Rhinology. 2017;55(1):34-8. 10.4193/Rhin16.025

24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8. 10.1006/meth.2001.1262

25. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77-83. 10.1111/j.1365-2222.1991.tb00807.x

26. AbuRuz SM, Bulatova NR, Tawalbeh MI. Development and validation of the Arabic allergic rhinitis quality of life questionnaire. Saudi Med J. 2009;30(12):1577-83.

27. Malmhall C, Bossios A, Pullerits T, Lotvall J. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Allergy. 2007;62(9):1007-13. 10.1111/j.1398-9995.2007.01420.x

28. Speth MM, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Treatment history and association between allergic rhinitis symptoms and quality of life. Ir J Med Sci. 2019;188(2):703-10. 10.1007/s11845-018-1866-2

29. Sawant DV, Wu H, Yao W, Sehra S, Kaplan MH, Dent AL. The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways. Immunology. 2015;145(1):11-23. 10.1111/imm.12393

30. Zhang S, Lin S, Tang Q, Yan Z. Knockdown of miR2055p alleviates the inflammatory response in allergic rhinitis by targeting Bcell lymphoma 6. Mol Med Rep. 2021; 24(5):818. 10.3892/mmr.2021.12458

31. Marino FZ, Aquino G, Brunelli M, Scognamiglio G, Pedron S, Ronchi A, et al. High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs. Virchows Arch. 2021;479(3):565-73. 10.1007/s00428-021-03084-8

32. Kilic K, Sakat MS, Yildirim S, Kandemir FM, Gozeler MS, Dortbudak MB, et al. The amendatory effect of hesperidin and thymol in allergic rhinitis: an ovalbumin-induced rat model. Eur Arch Otorhinolaryngol. 2019;276(2):407-15. 10.1007/s00405-018-5222-y

33. Liu W, Ota M, Tabushi M, Takahashi Y, Takakura Y. Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles. J Control Release. 2022;345:433-42. 10.1016/j.jconrel.2022.03.016

34. Zhang YZ, Luo J, Wang ZH, Wang J. Efficacy and safety of sublingual dust mite drops in children with mono-or polysensitized allergic rhinitis. Am J Otolaryngol. 2019;40(5):755-60. 10.1016/j.amjoto.2019.07.010

35. Shao YY, Zhou YM, Hu M, Li JZ, Chen CJ, Wang YJ, et al. The anti-allergic rhinitis effect of traditional Chinese medicine of shenqi by regulating mast cell degranulation and Th1/Th2 cytokine balance. Molecules. 2017; 22(3):504. 10.3390/molecules22030504

36. Bassil R, Orent W, Olah M, Kurdi AT, Frangieh M, Buttrick T, et al. BCL6 controls Th9 cell development by repressing Il9 transcription. J Immunol. 2014;193(1):198-207. 10.4049/jimmunol.1303184

37. Ogasawara T, Kohashi Y, Ikari J, Taniguchi T, Tsuruoka N, Watanabe-Takano H, et al. Allergic TH2 response governed by b-cell lymphoma 6 function in naturally occurring memory phenotype CD4(+) T cells. Front Immunol. 2018;9:750. 10.3389/fimmu.2018.00750

38. Lund R, Ahlfors H, Kainonen E, Lahesmaa AM, Dixon C, Lahesmaa R. Identification of genes involved in the initiation of human Th1 or Th2 cell commitment. Eur J Immunol. 2005;35(11):3307-19. 10.1002/eji.200526079

39. Dahanayake JM, Perera PK, Galappaththy P, Samaranayake D. Efficacy and safety of two Ayurvedic dosage forms for allergic rhinitis: Study protocol for an open-label randomized controlled trial. Trials. 2020;21(1):37. 10.1186/s13063-019-4004-1

40. Virchow JC, Kay S, Demoly P, Mullol J, Canonica W, Higgins V. Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients-an observational, cross sectional study in four countries in Europe. J Med Econ. 2011;14(3):305-14. 10.3111/13696998.2011.576039